An Overview of Insulin Pumps and Glucose Sensors for the Generalist

McAdams, Brooke; Rizvi, Ali A.

doi:10.3390/jcm5010005

Cited by 95 publications

(64 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, deep brain stimulation can be used for diverse neurodiseases such as Parkinson's disease or depression. Another popular application of active implants is drug delivery pumps such as the insulin pump or the intrathecal pump (Figure h). These devices are usually a substitute for oral drug administration to enhance drug delivery and therapeutic efficiency.…”

Section: Bioinert Non‐degradable Medical Implantsmentioning

confidence: 99%

Bioresorbable Electronic Implants: History, Materials, Fabrication, Devices, and Clinical Applications

Doo

Kang

Lee

et al. 2019

Adv Healthcare Materials

View full text Add to dashboard Cite

Medical implants, either passive implants for structural support or implantable devices with active electronics, have been widely used for the diagnosis and treatment of various diseases and clinical issues. These implants offer various functions, including mechanical support of biological structures in orthopedic and dental applications, continuous electrophysiological monitoring and feedback of electrical stimulation in neuronal and cardiac applications, and controlled drug delivery while maintaining arterial structure in drug‐eluting stents. Although these implants exhibit long‐term biocompatibility, surgery for their retrieval is often required, which imposes physical, biological, and economical burdens on the patients. Therefore, as an alternative to such secondary surgeries, bioresorbable implants that disappear after a certain period of time inside the body, including bioresorbable active electronics, have been highlighted recently. This review first discusses the historical background of medical implants and briefly define related terminology. Representative examples of non‐degradable medical implants for passive structural support and/or for diagnosis and therapy with active electronics are also provided. Then, recent progress in bioresorbable active implants composed of biosignal sensors, actuators for therapeutics, wireless power supply components, and their integrated systems are reviewed. Finally, clinical applications of these bioresorbable electronic implants are exemplified with brief conclusion and future outlook.

show abstract

Section: Bioinert Non‐degradable Medical Implantsmentioning

confidence: 99%

Bioresorbable Electronic Implants: History, Materials, Fabrication, Devices, and Clinical Applications

Doo

Kang

Lee

et al. 2019

Adv Healthcare Materials

View full text Add to dashboard Cite

show abstract

“…The Virtex-7 XC7VX690T FPGA can calculate 42 unified IVGTT systems simultaneously. Glucose monitoring sensors usually produce aver-aged readings every 3-5 minutes (McAdams, Rizvi 2016) and the glucose signal is acquired with the interval in the order of seconds (Olczuk, Priefer 2018). For the following calculation the interval of 1 s will be used.…”

Section: Results Of Multiple Simultaneous Metabolic P System Implemenmentioning

confidence: 99%

Research of Metabolic P System Field Programmable Gate Array Implementation

Kulakovskis¹

2019

View full text Add to dashboard Cite

Disertacija rengta 2014-2019 metais Vilniaus Gedimino technikos universitete. Vadovas prof. dr. Dalius NAVAKAUSKAS (Vilniaus Gedimino technikos universitetas, elektros ir elektronikos inžinerija-T 001). Vilniaus Gedimino technikos universiteto Elektros ir elektronikos inžinerijos mokslo krypties disertacijos gynimo taryba: Pirmininkas prof. dr. Vytautas URBANAVIČIUS (Vilniaus Gedimino technikos universitetas, elektros ir elektronikos inžinerija-T 001). Nariai: prof. dr. Algirdas BAŠKYS (Vilniaus Gedimino technikos universitetas, elektros ir elektronikos inžinerija-T 001), prof. habil. dr. Gintautas DZEMYDA (Vilniaus universitetas, informatikos inžinerija-T 007), dr. Ofer HADAR (Negevo Ben-Guriono universitetas, Izraelis, elektros ir elektronikos inžinerija-T 001), prof. dr. Jurij NOVICKIJ (Vilniaus Gedimino technikos universitetas, elektros ir elektronikos inžinerija-T 001). Disertacija bus ginama viešame Elektros ir elektronikos inžinerijos mokslo krypties disertacijos gynimo tarybos posėdyje 2019 m. gegužės 31 d. 13 val. Vilniaus Gedimino technikos universiteto senato posėdžių salėje.

show abstract

“…While multiple daily insulin injections (MDI) remain the main delivery method of insulin therapy globally, both MDI and CSII are recommended . However, the focus of insulin delivery is shifting towards the latter as a method considered more physiologically representative of a fully functioning pancreas . CSII has been shown to yield particular benefits over MDI, for example, lower cardiovascular mortality, higher treatment satisfaction and improved glucose control .…”

Section: Introductionmentioning

confidence: 99%

The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis

Reidy

Bracher

Foster

et al. 2018

Health Expectations

View full text Add to dashboard Cite

BackgroundInsulin pump therapy (IPT) is a technological advancement that has been developed to help people manage Type 1 diabetes (T1D). However, ways of managing diabetes requiring the implementation of health technologies bring new complexities and a need to understand the factors which enable people with T1D to incorporate a novel device. This new comprehension could provide an exemplar for people with long‐term conditions to incorporate new technologies more generally.ObjectiveTo determine what influences the incorporation, adaptation and use of IPT into the everyday lives of people living with diabetes.DesignCritical interpretive synthesis (CIS) using systematic searches undertaken in 7 electronic databases of literature, published 2008 onwards.ResultsA total of 4998 titles were identified, 274 abstracts reviewed, 39 full articles retrieved and 22 papers selected for analysis. Three themes emerged which were of relevance to the introduction and use of IPT; Tensions between expectations and experiences in adoption and early adaptation; Negotiation of responsibility and accessing support; Reflexivity, active experimentation and feedback.ConclusionsThis CIS builds on earlier reviews on lived experiences of IPT. Novel insights are offered through examination of the experiences of pump users from children through to adults, their families and health‐care professionals. Expectations of what the device can do to improve self‐management impacts on the early stages of adoption as the reality of the technology requires substantial thought and action. Areas for intervention to improve IPT incorporation include establishing who is responsible for management tasks of the device and enabling navigation to further means of support and resources.

show abstract

An Overview of Insulin Pumps and Glucose Sensors for the Generalist

Cited by 95 publications

References 39 publications

Bioresorbable Electronic Implants: History, Materials, Fabrication, Devices, and Clinical Applications

Bioresorbable Electronic Implants: History, Materials, Fabrication, Devices, and Clinical Applications

Research of Metabolic P System Field Programmable Gate Array Implementation

The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis

Contact Info

Product

Resources

About